In China, domestic trade in both tiger and rhinoceros products has been banned since 1993 and the maximum penalty for illicit trade is death. This report documents the progress made in implementing the ban but also the continuing availability of rhinoceros horn, tiger bone and their medicinal derivatives in the country.
Discussions in this report address bear farming in China, Hong Kong's gall bladder registration scheme, biological implications of the legal trade in bear gall bladder in Japan and Taiwan's efforts to monitor its domestic market for bear gall bladder. Recommendations are given to better understand, monitor and control the trade.
A focus on the use of tiger bone as a medicinal, this review compiles what is known of the current status of tiger populations, the uses and value of tiger bone and the global extent of the trade. It gives recommendations for tiger conservation based on the report's findings.